61 related articles for article (PubMed ID: 1803608)
21. [Hyperexpression of the multiple drug resistance gene (MDR-1) in chronic myeloleukemia patients].
Stiuf IIu; Bykova TV; Zaritskiĭ AIu; Frolova OI; Marinets OV; Afanas'ev BV
Ter Arkh; 1998; 70(7):26-9. PubMed ID: 9742631
[TBL] [Abstract][Full Text] [Related]
22. [Parameters significant for the prognosis of chronic myeloid leukemia in the chronic phase].
Maras J; Ribicić I; Maras-Simunić M; Skare L
Acta Med Iugosl; 1990; 44(4):389-97. PubMed ID: 2091442
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiological analysis of leukemia survival in Cracow for cases registered in 1980-1990].
Fornal M; Janicki K; Grodzicki T
Przegl Epidemiol; 2003; 57(4):671-82. PubMed ID: 15029843
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance protein expression in chronic myeloid leukemia: associations and significance.
Giles FJ; Kantarjian HM; Cortes J; Thomas DA; Talpaz M; Manshouri T; Albitar M
Cancer; 1999 Sep; 86(5):805-13. PubMed ID: 10463979
[TBL] [Abstract][Full Text] [Related]
25. The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
Hasford J; Pfirrmann M; Shepherd P; Guilhot J; Hehlmann R; Mahon FX; Kluin-Nelemans HC; Ohnishi K; Steegmann JL; Thaler J
Haematologica; 2005 Mar; 90(3):335-40. PubMed ID: 15749665
[TBL] [Abstract][Full Text] [Related]
26. Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.
Hasford J; Pfirrmann M; Hehlmann R; Baccarani M; Guilhot F; Mahon FX; Kluin-Nelemans HC; Ohnishi K; Thaler J; Steegmann JL;
Semin Hematol; 2003 Jan; 40(1):4-12. PubMed ID: 12563607
[TBL] [Abstract][Full Text] [Related]
27. Detection of high risk patients in chronic myelogenous leukemia by DNA-image cytometry.
Muller CP; Kropff M; Biesterfeld S; Chatelain R; Wagner A; Wohltmann D; Böcking A
Anticancer Res; 1991; 11(2):617-23. PubMed ID: 2064316
[TBL] [Abstract][Full Text] [Related]
28. Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score).
Bacigalupo A; Gualandi F; Van Lint MT; Sessarego M; Frassoni F; Occhini D; Lamparelli T; Oneto R; Vitale V; Corvo R
Bone Marrow Transplant; 1993 Nov; 12(5):443-8. PubMed ID: 8298554
[TBL] [Abstract][Full Text] [Related]
29. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
30. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
31. Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
Cortes J; Talpaz M; O'Brien S; Jones D; Luthra R; Shan J; Giles F; Faderl S; Verstovsek S; Garcia-Manero G; Rios MB; Kantarjian H
Clin Cancer Res; 2005 May; 11(9):3425-32. PubMed ID: 15867244
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognostic features of Nigerians with chronic myeloid leukemia.
Boma PO; Durosinmi MA; Adediran IA; Akinola NO; Salawu L
Niger Postgrad Med J; 2006 Mar; 13(1):47-52. PubMed ID: 16633379
[TBL] [Abstract][Full Text] [Related]
34. [The prognostic significance of the differential blood count in patients with chronic myeloid leukemia].
Zankovich R; Schilling H; Thiele J; Kvasnicka HM; Diehl V
Med Klin (Munich); 1989 Aug; 84(8):373-7. PubMed ID: 2796866
[TBL] [Abstract][Full Text] [Related]
35. [Cox's regression analysis of prognostic factors in differentiated thyroid carcinomas].
Tsuchiya A; Suzuki S; Kanno M; Urazumi K; Rokkaku Y; Kimijima I; Abe R
Gan No Rinsho; 1990 Jan; 36(1):13-8. PubMed ID: 2299788
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors in tumors of the upper urinary tract].
Ruiz-Cerdá JL; Morera Martínez J; Pontones Moreno JL; Vera Donoso C; Martínez Javaloyas J; Osca García JM; Jiménez Cruz JF
Actas Urol Esp; 1993 Oct; 17(9):547-54. PubMed ID: 8165936
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
38. [The functional activity of blood neutrophils in chronic myeloleukemia].
Asadov ChD; Numerova LS
Lab Delo; 1990; (10):59-61. PubMed ID: 1704464
[No Abstract] [Full Text] [Related]
39. [Changes in the level of extracellular DNA and free polyamines in the blood of patients with chronic myeloleukemia].
Pan'kov VN; Voronchikhina LD; Dem'ianova VT; Beznosikova TP; Kolupaeva NV
Gematol Transfuziol; 1988 Aug; 33(8):45-8. PubMed ID: 3192057
[No Abstract] [Full Text] [Related]
40. [The role of the neutrophil link in phagocytosis in the pathogenesis of suppurative inflammatory complications in chronic myeloleukemia].
Guseva SA
Lik Sprava; 1995; (3-4):81-4. PubMed ID: 8819929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
